Ceftazidime Hikma Farmacêutica (Portugal)

Ceftazidime Hikma Farmacêutica (Portugal) is an intravenous antibiotic used to treat bacterial infections. This medication is part of the cephalosporin class and is manufactured by Hikma Farmacêutica (Portugal), S.A.

Ceftazidime is primarily used to treat a variety of bacterial infections, including those affecting the lungs, urinary tract, and skin. It is often prescribed for infections caused by gram-negative bacteria. Ceftazidime is administered intravenously and is commonly used in hospital settings to manage severe infections.

Common effects of Ceftazidime may include mild to moderate allergic reactions, such as rash or itching. Some individuals may experience gastrointestinal disturbances like nausea or diarrhea. Severe allergic reactions are rare but require immediate medical attention.

Ceftazidime should be used with caution in individuals with a history of allergic reactions to cephalosporins or penicillin. It is important to inform your healthcare provider about any existing medical conditions or allergies before starting treatment. Always follow the prescribed dosage and administration instructions provided by your healthcare professional.

Ceftazidime may interact with certain medications, including other antibiotics and drugs that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided during treatment with Ceftazidime.